Two new RSV vaccine candidates, made by Pfizer and GlaxoSmithKline, could become the world’s first approved shots against the common respiratory syncytial virus (RSV). The FDA, which typically follows the committee’s recommendations, is expected to decide on approval in May, ahead of RSV’s typical winter surge.
Source: www.cnn.com
Related posts:
Photos: Ukrainians celebrate religious holidays
Intercepting data traffic via iPhone
Shark in Monterey Bay attack was as long as an SUV, biologists say
Brazil sends swimmer home from Paris Olympics for leaving village without authorization
Kevin McLaughlin: Stop Biden's $3.5 trillion boondoggle – Manchin shows moderate Dems how to survive...